Citations

Mayo Clinic

Showing 10 of 108523 citations.

Life-Threatening tPA-Associated Angioedema: A Rare Case Report and Critical Review
Labban, Mohamad El , Zibaoui, Roba El , Amadi, Alpha C., Zareen, Tashfia, Khan, Syed Anjum , El Labban, Mohamad , Amadi, A.

American Journal of Case Reports | August 5, 2024 | Volume: 25 | Issue: No issue available | Pages: No page available

10.12659/ajcr.944221 | PMID 39275799 Get It

Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis
Dasgupta, Sayan , Stevens‐Ayers, Terry , Edmison, Bradley, Winston, Drew J., Razonable, Raymund R. , Lyon, G. Marshall, Singh, Nina, Razonable, Raymund R , Zamora, Danniel , Mehta, Aneesh K. , Boeckh, Michael , Koelle, David M. , Limaye, Ajit P.

JCI Insight | August 5, 2024 | Volume: 9 | Issue: 18 | Pages: No page available

10.1172/jci.insight.180115 | PMID 39099206 Get It

CMV-specific T cells, NK cells, and neutralizing antibodies (nAbs) were assessed in a randomized trial of CMV prevention with preemptive antiviral therapy (PET) versus prophylactic antiviral therapy (PRO) in donor-seropositive/recipient-seronegative (D + R – ) liver transplant recipients (LTxR) at 100 days (end of intervention) and at 6 and 12 months after transplant. The PET group had significantly increased numbers of circulating polyfunctional T cells, NK cells, and nAbs compared with the PRO group at day 100, and several CMV immune parameters remained significantly higher by 12 months after transplant. Among PET recipients, preceding CMV viremia (vs. no preceding viremia) was associated with significantly higher levels of most CMV immune parameters at day 100. Higher numbers of CMV-specific polyfunctional T cells and NKG2C + NK cells at day 100 were associated with a decreased incidence of CMV disease in multivariable Cox regression. The strongest associations with protection against CMV disease were with increased numbers of CMV-specific polyfunctional CD4 + T cells, CD3 neg CD56 dim CD57 neg NKG2C pos cells, and CD3 neg CD56 dim CD57 pos NKG2C pos NK cells. Our results suggest that PET is superior to PRO for CMV disease prevention by allowing low-level CMV replication and associated antigen exposure that is promptly controlled by antiviral therapy and facilitates enhanced CMV protective immunity in D + R – LTxR.
A case of erythema ab igne with histopathological features resembling keratosis lichenoides chronica
Shahin, Ahmad , Mastin, Murphy R., Lehman, Julia S. , Anderson, Katelyn , Shahin, Ahmad B , Coias, Jennifer , Lehman, Julia S

Pediatric Dermatology | August 5, 2024 | Volume: 42 | Issue: 1 | Pages: 196-198

10.1111/pde.15715 | PMID 39098008 Get It

AbstractThis case describes a pediatric patient with a history of ichthyosis vulgaris and global anhidrosis who was diagnosed with erythema ab igne (EAI), a rare dermatosis resulting from chronic heat exposure. After developing progressive, reticulated brown patches on his extremities and abdomen, extensive diagnostic investigations were conducted to rule out autoimmune, vascular, and genetic etiologies. Bloodwork was unrevealing and biopsies showed histologic features closely resembling keratosis lichenoides chronica. Ultimately, after discovering the patient had prolonged exposure to a space heater, the diagnosis of EAI was made. This case underscores the diagnostic challenges in pediatric EAI cases and emphasizes the importance of careful history taking as part of a comprehensive evaluation.
Girk3 deletion increases osteoblast maturation and bone mass accrual in adult male mice
Weaver, Samantha , Oliveira, Haydée Torres de , Arnold, Katherine M. , Zars, Elizabeth L. , Peralta-Herrera, Eduardo , Taylor, Earnest L., Yu, Kanglun , Velasco, Ezequiel Marrón Fernández de , Wickman, Kevin , Bradley, Elizabeth W. , Westendorf, Jennifer J., Weaver, Samantha R , Torres, Haydee M , Bradley, Elizabeth W , McGee‐Lawrence, Meghan E. , Westendorf, Jennifer J.

JBMR Plus | August 4, 2024 | Volume: 8 | Issue: 10 | Pages: No page available

10.1093/jbmrpl/ziae108 | PMID 39228688 Get It

Abstract Osteoporosis and other metabolic bone diseases are prevalent in the aging population. While bone has the capacity to regenerate throughout life, bone formation rates decline with age and contribute to reduced bone density and strength. Identifying mechanisms and pathways that increase bone accrual in adults could prevent fractures and accelerate healing. G protein-gated inwardly rectifying K+ (GIRK) channels are key effectors of G protein-coupled receptor signaling. Girk3 was recently shown to regulate endochondral ossification. Here, we demonstrate that deletion of Girk3 increases bone mass after 18 weeks of age. Male 24-week-old Girk3-/- mice have greater trabecular bone mineral density and bone volume fraction than wildtype (WT) mice. Osteoblast activity is moderately increased in 24-week-old Girk3-/- mice compared to WT mice. In vitro, Girk3-/- bone marrow stromal cells (BMSCs) are more proliferative than WT BMSCs. Calvarial osteoblasts and BMSCs from Girk3-/- mice are also more osteogenic than WT cells, with altered expression of genes that regulate the wingless-related integration site (Wnt) family. Wnt inhibition via Dickkopf-1 (Dkk1) or β-catenin inhibition via XAV939 prevents enhanced mineralization, but not proliferation, in Girk3-/- BMSCs and slows these processes in WT cells. Finally, selective ablation of Girk3 from cells expressing Cre recombinase from the 2.3 kb-Col1a1 promoter, including osteoblasts and osteocytes, is sufficient to increase bone mass and bone strength in male mice at 24 weeks of age. Taken together, these data demonstrate that Girk3 regulates progenitor cell proliferation, osteoblast differentiation, and bone mass accrual in adult male mice.
Simultaneous onset of chronic nonbacterial osteomyelitis in siblings
Patel, Jenny A. , Thomas, Kristen B. , Ristagno, Elizabeth H. , Basiaga, Matthew L.

Modern Rheumatology Case Reports | August 3, 2024 | Volume: 9 | Issue: 1 | Pages: 20-26

10.1093/mrcr/rxae035 | PMID 39096523 Get It

ABSTRACT Chronic nonbacterial osteomyelitis (CNO) is an uncommon autoinflammatory disorder. Significant effort has recently been spent to better define and treat this disorder including development of consensus treatment protocols, validate disease activity tools, and refining classification criteria. However, the underlying immunopathogenesis of the disease remains elusive. In this report, we describe the simultaneous onset of CNO in siblings. A pathogenic gene mutation was not identified, and these sisters lacked a similar biomarker profile. This report highlights that if a genetic predisposition for CNO exists, it may be related to complex polygenic or multifactorial mechanisms of disease evolution.
State inequities: Gaps in planned treatment for criminal legal referrals with opioid use disorder across two decades of US treatment admissions
Bormann, Nicholas L. , Weber, Andrea N. , Oesterle, Tyler , Miskle, Benjamin , Lynch, Alison C., Arndt, Stephan , Oesterle, Tyler S , Bormann, Nicholas L , Lynch, Alison C.

The American Journal on Addictions | August 3, 2024 | Volume: 34 | Issue: 1 | Pages: 60-68

10.1111/ajad.13636 | PMID 39096196 Get It

AbstractBackground and ObjectivesCriminal‐legal (CL) referrals to addiction treatment have historically had low utilization of medications for opioid use disorder (MOUD). While state differences have been reported, an in‐depth longitudinal analysis of state‐by‐state differences is lacking.MethodsThe Substance Abuse and Mental Health Services Administration Treatment Episode Dataset‐Admissions 2000–2020 provided data for individuals entering their initial treatment with an opioid as their primary substance. Outcome was planned use of MOUD, assessing odds ratio (OR) of CL referrals relative to non‐CL referrals cumulatively over the 21‐year period and as incremental change (change in relative disparity) using effect sizes, stratified by each state.Results2,187,447 cases met the criteria. Planned MOUD occurred in 37.7% of non‐CL clients versus 6.5% of CL clients (OR = 0.11, 95% confidence interval = 0.11–0.12). For all clients, planned MOUD increased from 2000 (33.9%) to 2020 (44.8%). This increase was blunted within CL clients, increasing from 2000 (6.4%) to 2020 (13.3%). Rhode Island saw the greatest improvements in equity.Discussion and ConclusionsWhile rates of planned MOUD increased over the 21 years, a significant disparity persisted among CL clients in most states. As opioid use disorders and opioid‐related overdoses are more prevalent among those involved with the CL system, improving this has high impact.Scientific SignificanceProvides the most comprehensive analysis of state‐by‐state inequities in MOUD access for CL relative to non‐CL referrals over a 21‐year period through use of a national data set. Positive outliers are used as case examples for others to follow in pursuit of more equitable care.
Familial autoimmunity and risk of developing immune thrombocytopenia and Evans syndrome
Chinga, Michell Lozano , Bussel, James B. , Fluchel, Mark , Wilkes, Jacob , Meeks, Huong , Meznarich, Jessica , Lozano Chinga, Michell M , Meeks, Huong , Meznarich, Jessica A , Zhang, Chong

Pediatric Blood & Cancer | August 3, 2024 | Volume: 71 | Issue: 10 | Pages: No page available

10.1002/pbc.31239 | PMID 39096193 Get It

AbstractBackgroundImmune thrombocytopenia (ITP) and Evans syndrome (ES) are manifestations of immune dysregulation. Genetic variants in immune‐related genes have been identified in patients with ITP and especially ES. We aimed to explore familial autoimmunity in patients with ITP and ES to understand possible contributions to chronicity.ProcedureWe assessed family history in two ways: via patient report for ITP and ES and by population‐based analysis using the Utah Population Database (UPDB) for ITP. A total of 266 patients with ITP and 21 patients with ES were identified via chart review, and 252 of the 266 patients with ITP were also identified in the UPDB.ResultsChart review showed familial autoimmunity in 29/182 (15.9%) and 25/84 (29.8%) of patients with newly diagnosed+persistent (nd+p) ITP and chronic ITP (cITP), respectively, (p = .009). The UPDB analysis revealed that autoimmunity in relatives of patients with nd+pITP was higher than in relatives of controls (odds ratio [OR]: 1.69 [1.19–2.41], p = .004), but was not significantly increased in relatives of patients with cITP (OR 1.10 [0.63–1.92], p = .734). Incomplete family history in medical records likely contributed to the observed discrepancy.ConclusionsThe findings suggest that familial autoimmunity may have a stronger association with the development of ITP rather than its duration. Twelve (57.1%) patients with ES reported autoimmunity in their relatives. UPDB analysis was omitted due to the small number of patients with ES. The use of population databases offers a unique opportunity to assess familial health and may provide clues about contributors to immune dysregulation features within families.
Association of county level poverty with mortality from primary liver cancers
Ledenko, Matthew , Patel, Tushar , Patel, Tushar

Cancer Medicine | August 3, 2024 | Volume: 13 | Issue: 15 | Pages: No page available

10.1002/cam4.7463 | PMID 39096101 Get It

AbstractBackgroundThe highly variable occurrence of primary liver cancers across the United States emphasize the relevance of location‐based factors. Social determinants such as income, educational attainment, housing, and other factors may contribute to regional variations in outcomes. To evaluate their impact, this study identified and analyzed clusters of high mortality from primary liver cancers and the association of location‐based determinants with mortality across the contiguous United States.MethodsA geospatial analysis of age‐adjusted incidence and standardized mortality rates from primary liver cancers from 2000 to 2020 was performed. Local indicators of spatial association identified hot‐spots, clusters of counties with significantly higher mortality. Temporal analysis of locations with persistent poverty, defined as high (>20%) poverty for at least 30 years, was performed. Social determinants were analyzed individually or globally using composite measures such as the social vulnerability index or social deprivation index. Disparities in county level social determinants between hot‐spots and non‐hot‐spots were analyzed by univariate and multivariate logistic regression.ResultsThere are distinct clusters of liver cancer incidence and mortality, with hotspots in east Texas and Louisiana. The percentage of people living below the poverty line or Hispanics had a significantly higher odds ratio for being in the top quintile for mortality rates in comparison to other quintiles and were highly connected with mortality rates. Current and persistent poverty were both associated with an evolution from non‐hotspots to new hotspots of mortality. Hotspots were predominantly associated with locations with significant levels of socioeconomic vulnerability or deprivation.ConclusionsPoverty at a county level is associated with mortality from primary liver cancer and clusters of higher mortality. These findings emphasize the importance of addressing poverty and related socio‐economic determinants as modifiable factors in public health policies and interventions aimed at reducing mortality from primary liver cancers.
Racial and ethnic disparities in the natural history of alcohol‐associated liver disease in the United States
Ayares, Gustavo , Díaz, Luis Antonio , Fuentes–López, Eduardo , Idalsoaga, Francisco , Cotter, Thomas G. , Dunn, Winston , Shah, Vijay H. , Kamath, Patrick S. , Lazarus, Jeffrey V. , Simonetto, Douglas A , Kamath, Patrick S , Lazarus, Jeffrey V , Bataller, Ramon A , Arrese, Marco , Wong, Robert J , Singal, Ashwani K , Arab, Juan P , Cotter, T G , Díaz, Luis A , Ayares, Gustavo , Dunn, Winston , Simonetto, Douglas A. , Arrese, Marco , Wong, Robert J. , Singal, Ashwani K. , Arab, Juan Pablo

Liver International | August 3, 2024 | Volume: 44 | Issue: 10 | Pages: 2822-2833

10.1111/liv.16023 | PMID 39096099 Get It

Abstract Background Outcomes in alcohol‐associated liver disease (ALD) are influenced by several race and ethnic factors, yet its natural history across the continuum of patients in different stages of the disease is unknown. Methods We conducted a retrospective cohort study of U.S. adults from 2011 to 2018, using three nationally representative databases to examine potential disparities in relevant outcomes among racial and ethnic groups. Our analysis included logistic and linear regressions, along with competing risk analysis. Results Black individuals had the highest daily alcohol consumption (12.6 g/day) while Hispanic participants had the largest prevalence of heavy episodic drinking (33.5%). In a multivariable‐adjusted model, Hispanic and Asian participants were independently associated with a higher ALD prevalence compared to Non‐Hispanic White interviewees (OR: 1.4, 95% CI: 1.1–1.8 and OR: 1.5 95% CI:1.1–2.0, respectively), while Blacks participants had a lower ALD prevalence (OR: .7 95% CI: .6–.9), and a lower risk of mortality during hospitalization due to ALD (OR: .83 95% CI: .73–.94). Finally, a multivariate competing‐risk analysis showed that Hispanic ethnicity had a decreased probability of liver transplantation if waitlisted for ALD (SHR: .7, 95% CI: .6–.8) along with female Asian population (HR: .40, 95% CI: .26–.62). Conclusions After accounting for key social and biological health determinants, the Hispanic population showed an increased risk of ALD prevalence, even with lower alcohol consumption. Additionally, Hispanic and Asian female patients had reduced access to liver transplantation compared to other enlisted patients.
Using multistate models with clinical trial data for a deeper understanding of complex disease processes
Therneau, Terry M. , Ou, Fang‐Shu , Ou, Fang-Shu

Clinical Trials | August 3, 2024 | Volume: 21 | Issue: 5 | Pages: 531-540

10.1177/17407745241267862 | PMID 39095982 Get It

A clinical trial represents a large commitment from all individuals involved and a huge financial obligation given its high cost; therefore, it is wise to make the most of all collected data by learning as much as possible. A multistate model is a generalized framework to describe longitudinal events; multistate hazards models can treat multiple intermediate/final clinical endpoints as outcomes and estimate the impact of covariates simultaneously. Proportional hazards models are fitted (one per transition), which can be used to calculate the absolute risks, that is, the probability of being in a state at a given time, the expected number of visits to a state, and the expected amount of time spent in a state. Three publicly available clinical trial datasets, colon, myeloid, and rhDNase, in the survival package in R were used to showcase the utility of multistate hazards models. In the colon dataset, a very well-known and well-used dataset, we found that the levamisole+fluorouracil treatment extended time in the recurrence-free state more than it extended overall survival, which resulted in less time in the recurrence state, an example of the classic “compression of morbidity.” In the myeloid dataset, we found that complete response (CR) is durable, patients who received treatment B have longer sojourn time in CR than patients who received treatment A, while the mutation status does not impact the transition rate to CR but is highly influential on the sojourn time in CR. We also found that more patients in treatment A received transplants without CR, and more patients in treatment B received transplants after CR. In addition, the mutation status is highly influential on the CR to transplant transition rate. The observations that we made on these three datasets would not be possible without multistate models. We want to encourage readers to spend more time to look deeper into clinical trial data. It has a lot more to offer than a simple yes/no answer if only we, the statisticians, are willing to look for it.